Non‐Subtractive Arterial Spin Labeling‐Based ( NSASL ) Renal Magnetic Resonance Angiography ( MRA ): Development and Clinical Feasibility Evaluation
Journal of Magnetic Resonance Imaging · 2026
DOI: 10.1002/jmri.70220 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Magnetic Resonance Imaging, 2026. Verfasst von Yulin Wang und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Electrical and Electronic Engineering, Faculty of Science and Engineering, University of Nottingham Ningbo China, Ningbo, Zhejiang, Chi…. Hauptthemen laut MEDLINE: Magnetic Resonance Angiography, Renal Artery, Kidney. Die Arbeit nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Ningbo "S&T Innovation 2035" Major program, National Key Research and Development Program of China.
Abstract (Originalsprache)
Background
Non‐contrast renal MR angiography (MRA) is valuable for patients who cannot receive contrast agents or when avoiding radiation is desired. However, the conventional inflow inversion recovery (IFIR) method is limited by incomplete background suppression, venous contamination, and motion sensitivity.
Purpose
To develop and evaluate a non‐subtractive arterial spin labeling‐based (NSASL) sequence for renal MRA and compare it with IFIR in healthy volunteers, with exploratory feasibility assessment relative to contrast‐enhanced (CE)‐MRA or computed tomography angiography (CTA) in patients. Study Type Prospective. Subjects Thirty healthy volunteers (10 male, 35.6 14.0 years) and six participants with renal diseases or high blood pressure (2 male, 62.7 9.03 years). Field Strength/Sequence 1.5 T; 3D stack‐of‐stars balanced steady‐state free precession (bSSFP) NSASL MRA, 3D Cartesian bSSFP IFIR MRA, and CE‐MRA. Assessment Three radiologists independently rated image quality (main and branch renal arteries visualization, motion artifacts, vessel‐to‐background contrast, diagnostic confidence) on a 5‐point scale. SNR efficiency (or SNR and time) and contrast ratio (CR) were also measured. Statistical Tests Intraclass coefficient (ICC), Shapiro–Wilk's test, paired Student's t‐ test, and Wilcoxon signed‐rank test with Bonferroni correction, with p < 0.05 considered statistically significant.
Results
ICC was good to excellent (ICC = 0.61–0.89) for average subjective scores. Compared with IFIR, NSASL showed significantly better vessel‐to‐background contrast (approximately fivefold increase in CR, Cohen's | d | = 2.54; +1 subjective score, | r | = 0.88), improved renal arteries visualization (+0.7 points, | r | = 0.67, corrected p 0.003), fewer motion artifacts (+0.6 points, | r | = 0.67, corrected p = 0.002), and higher diagnostic confidence (+0.6 points, | r | = 0.80, corrected p < 0.001). Acquisition time was reduced from 267.3 ± 69.0 s to 240.2 ± 51.3 s (Cohen's | d | = 0.54, corrected p = 0.018) while SNR efficiency was moderately lower (~26%, Cohen's | d | = 1.99, corrected p = 0.002). In participants with disease, NSASL yielded similar diagnostic confidence to CE‐MRA ( n = 4, +0.7 points, p = 0.194) and to CTA ( n = 2, −0.2 points, p = 0.317). Data Conclusion NSASL significantly outperformed IFIR, with improved background suppression, vessel conspicuity, motion tolerance, and scan time in healthy volunteers. Evidence Level 2. Technical Efficacy Stage 2.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Electrical and Electronic Engineering, Faculty of Science and Engineering, University of Nottingham Ningbo China, Ningbo, Zhejiang, China.
- Department of Radiology, Ningbo Number 2 Hospital, Ningbo, Zhejiang, China.
- Xingaoyi Medical Equipment Co. Ltd., Ningbo, Zhejiang, China.
- Department of Medical Imaging, Quanzhou Medical College, Quanzhou, Fujian, China.
- Department for Strategic Development of Health Science and Technology, University of Nottingham Ningbo China, Ningbo, Zhejiang, China.
- Sir Peter Mansfield Imaging Center, University of Nottingham, Nottingham, UK.
ORCID-Profile: Yulin Wang, Ye Yuan, Chengbo Wang
Förderung
- Ningbo "S&T Innovation 2035" Major program
- National Key Research and Development Program of China
Zitieren
APA
Wang, Y., Yuan, Y., Yan, K., Zhang, J., Zeng, J., Niu, S., Ke, S., Yao, C., Chen, B., Dai, Q., Guo, L., Zheng, J., Meersmann, T., & Wang, C. (2026). Non‐Subtractive Arterial Spin Labeling‐Based ( NSASL ) Renal Magnetic Resonance Angiography ( MRA ): Development and Clinical Feasibility Evaluation. Journal of Magnetic Resonance Imaging. https://doi.org/10.1002/jmri.70220
Vancouver
Wang Y, Yuan Y, Yan K, Zhang J, Zeng J, Niu S, et al. Non‐Subtractive Arterial Spin Labeling‐Based ( NSASL ) Renal Magnetic Resonance Angiography ( MRA ): Development and Clinical Feasibility Evaluation. Journal of Magnetic Resonance Imaging. 2026. doi:10.1002/jmri.70220
BibTeX
@article{Wang2026,
author = {Wang, Yulin and Yuan, Ye and Yan, Kun and Zhang, Jichang and Zeng, Jie and Niu, Shengyang and Ke, Shiying and Yao, Chendie and Chen, Bin and Dai, Qi and Guo, Liping and Zheng, Jianjun and Meersmann, Thomas and Wang, Chengbo},
title = {Non‐Subtractive Arterial Spin Labeling‐Based ( NSASL ) Renal Magnetic Resonance Angiography ( MRA ): Development and Clinical Feasibility Evaluation},
journal = {Journal of Magnetic Resonance Imaging},
year = {2026},
doi = {10.1002/jmri.70220}
}
EUVIMED